IL98812A0 - Purine derivatives,process for their preparation and pharmaceutical compositions containing them - Google Patents

Purine derivatives,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL98812A0
IL98812A0 IL98812A IL9881291A IL98812A0 IL 98812 A0 IL98812 A0 IL 98812A0 IL 98812 A IL98812 A IL 98812A IL 9881291 A IL9881291 A IL 9881291A IL 98812 A0 IL98812 A0 IL 98812A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
purine derivatives
purine
Prior art date
Application number
IL98812A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL98812A0 publication Critical patent/IL98812A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL98812A 1990-07-18 1991-07-12 Purine derivatives,process for their preparation and pharmaceutical compositions containing them IL98812A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH238790 1990-07-18

Publications (1)

Publication Number Publication Date
IL98812A0 true IL98812A0 (en) 1992-07-15

Family

ID=4232597

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98812A IL98812A0 (en) 1990-07-18 1991-07-12 Purine derivatives,process for their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
EP (1) EP0467207A3 (fr)
JP (1) JPH04234391A (fr)
KR (1) KR920002600A (fr)
AU (1) AU8038491A (fr)
CA (1) CA2044806A1 (fr)
FI (1) FI913407A7 (fr)
HU (1) HU209591B (fr)
IE (1) IE912500A1 (fr)
IL (1) IL98812A0 (fr)
MC (1) MC2278A1 (fr)
NO (1) NO912804L (fr)
PT (1) PT98348A (fr)
ZA (1) ZA915418B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5202328A (en) * 1991-03-06 1993-04-13 Merck & Co., Inc. Substituted fused pyrimidinones
TW274551B (fr) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
PE20030008A1 (es) 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
EP2527360B1 (fr) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (fr) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
EP3241839B1 (fr) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (fr) * 1986-07-11 1995-01-24 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use

Also Published As

Publication number Publication date
JPH04234391A (ja) 1992-08-24
ZA915418B (en) 1992-03-25
HU209591B (en) 1994-08-29
NO912804D0 (no) 1991-07-17
FI913407A0 (fi) 1991-07-15
EP0467207A2 (fr) 1992-01-22
CA2044806A1 (fr) 1992-01-19
AU8038491A (en) 1992-01-23
EP0467207A3 (en) 1992-08-12
NO912804L (no) 1992-01-20
HUT58736A (en) 1992-03-30
FI913407A7 (fi) 1992-01-19
HU912347D0 (en) 1991-12-30
IE912500A1 (en) 1992-01-29
PT98348A (pt) 1992-05-29
KR920002600A (ko) 1992-02-28
MC2278A1 (fr) 1993-06-23

Similar Documents

Publication Publication Date Title
ZA916583B (en) 3-amidopyrazole derivatives,process for preparing these and pharmaceutical compositions containing them
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
IL92798A0 (en) Benzimidazole derivatives,process for their preparation and pharmaceutical compositions containing them
IL103126A (en) 5-amino-4-hydroxyhexanoic acid derivatives, process for their preparation and pharmaceutical compositions containing them
IL117104A (en) Tetrahydrocarbazole derivatives, process for their preparation and pharmaceutical compositions containing them
LTIP1713A (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
IL100262A0 (en) Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them
HUT58303A (en) Process for producing pyrimidinyl derivatives and pharmaceutical compositions containing them
IL98864A0 (en) Oxazolyl derivatives,process for their preparation and pharmaceutical compositions containing them
IL98164A0 (en) Antiviral nucleoside derivatives,process for their preparation and pharmaceutical compositions containing them
GR3021933T3 (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
IL98812A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions containing them
IL87856A0 (en) Alkadiene derivatives,process for their preparation and pharmaceutical compositions containing them
IL97656A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions comprising them
IL88138A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL94485A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions containing them
EP0285089A3 (en) 4-thioquinazoline derivatives, processes for their preparation and pharmaceutical compositions
AU8917891A (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
ZA902591B (en) Thiouracil derivatives,pharmaceutical compositions containing them and process for preparing same
IL99469A0 (en) Imidazoline derivatives,process for their preparation and pharmaceutical compositions containing them
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
IL81978A (en) Indenopyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
IL82333A (en) Substituted 2-phenylbenzothiazin-3-one derivatives,process for their preparation and pharmaceutical compositions containing them
ZA912975B (en) Serotonin-antagonist naphthosultam derivatives,their preparation and pharmaceutical compositions containing them
ZA903008B (en) Macrolide derivatives,process for preparing them and pharmaceutical compositions containing them